Compare Eli Lilly And Co (LLY) vs Public Storage (PSA) Price & Performance

Eli Lilly (LLY) trades at $1,150.86, down 2.39% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $8.55 exceeding expectations by 23%. Revenue surged to $65.18 billion in 2025, driving a net income margin of 34.99%. Recent news highlights LLY's $2.8 billion acquisition of AtaiBeckley to expand its neuroscience pipeline, signaling strategic growth in mental health treatments.

Outlook remains positive with analyst consensus price target of $1,380 implying 20% upside, supported by 73% buy ratings. Key risks include high valuation multiples (P/E 41.89) and rising debt levels, though operating cash flow growth to $16.81 billion in 2025 provides financial flexibility. Investors should monitor Q2 2026 earnings on August 5 for continued execution on weight-loss drug demand and integration of recent acquisitions.

Public Storage (PSA) trades at $315.45, down 0.81% on the day, with a neutral technical signal and mixed moving averages. The company shows strong profitability with 39.16% net income margin and 33.78% ROE, though valuation ratios appear elevated with P/E of 32.86. Recent developments include the pending acquisition of National Storage Affiliates and consistent earnings beats in recent quarters.

The outlook remains cautiously optimistic with a $332.25 consensus price target representing 5.3% upside. Key opportunities include expansion into Canadian markets and operational efficiencies, while risks involve integration challenges from acquisitions and potential interest rate sensitivity. Analyst consensus leans neutral with 65.72% hold ratings amid valuation concerns.